Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Ocugen Inc (OCGN)

Ocugen Inc (OCGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 437,502
  • Shares Outstanding, K 257,354
  • Annual Sales, $ 6,040 K
  • Annual Income, $ -63,080 K
  • 60-Month Beta 3.65
  • Price/Sales 69.92
  • Price/Cash Flow N/A
  • Price/Book 13.90
Trade OCGN with:

Options Overview Details

View History
  • Implied Volatility 109.21% ( -9.47%)
  • Historical Volatility 79.34%
  • IV Percentile 6%
  • IV Rank 9.31%
  • IV High 1,030.35% on 11/09/23
  • IV Low 14.65% on 08/14/23
  • Put/Call Vol Ratio 0.17
  • Today's Volume 1,023
  • Volume Avg (30-Day) 2,288
  • Put/Call OI Ratio 0.16
  • Today's Open Interest 52,995
  • Open Int (30-Day) 68,854

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.06
  • Number of Estimates 1
  • High Estimate -0.06
  • Low Estimate -0.06
  • Prior Year -0.10
  • Growth Rate Est. (year over year) +40.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1500 +47.83%
on 06/26/24
1.9790 -14.10%
on 07/16/24
+0.3700 (+27.82%)
since 06/21/24
3-Month
1.1100 +53.15%
on 04/25/24
2.0600 -17.48%
on 05/16/24
+0.4500 (+36.00%)
since 04/23/24
52-Week
0.3450 +392.75%
on 10/26/23
2.1050 -19.24%
on 03/25/24
+1.0990 (+182.86%)
since 07/21/23

Most Recent Stories

More News
1 Biotech Stock to Buy Hand Over Fist and 1 to Avoid

These two stocks could have vastly different long-term performances.

CRSP : 57.19 (+1.69%)
OCGN : 1.7000 (+3.66%)
1 Stock That More Than Doubled This Year That I Wouldn't Touch With a 10-Foot Pole

Don't jump on the bandwaggon.

OCGN : 1.7000 (+3.66%)
Can Ocugen Stock Keep Churning Higher?

This tiny biotech caught fire in 2024. Can it sustain the momentum?

RHHBY : 38.2000 (-2.95%)
VHT : 272.90 (+0.06%)
OCGN : 1.7000 (+3.66%)
3 Standout Penny Stocks to Watch This April

Investing in penny stocks carries substantial risk, but also offers the potential for significant returns. These penny stocks, all with bullish analyst ratings, have considerable upside potential, according...

OCGN : 1.7000 (+3.66%)
VERU : 0.9750 (+1.57%)
DM : 5.15 (unch)
$SPX : 5,555.74 (-0.16%)
Ocugen (OCGN) Q4 2023 Earnings Call Transcript

OCGN earnings call for the period ending March 31, 2024.

OCGN : 1.7000 (+3.66%)
Two Beaten-Down Stocks That Could Soar 170% and 630%, Respectively, According to Wall Street

Could these biotech companies still win in the vaccine market and beyond?

NVAX : 16.39 (+9.71%)
OCGN : 1.7000 (+3.66%)
Ocugen (OCGN) Q3 2023 Earnings Call Transcript

OCGN earnings call for the period ending September 30, 2023.

OCGN : 1.7000 (+3.66%)
Ocugen (OCGN) Q2 2023 Earnings Call Transcript

OCGN earnings call for the period ending June 30, 2023.

OCGN : 1.7000 (+3.66%)
Wall Street Expects These Stocks to Soar 175% and 545%. Should You Buy?

These companies haven't given up on the coronavirus vaccine market.

MRNA : 121.25 (-1.02%)
PFE : 29.50 (-0.34%)
NVAX : 16.39 (+9.71%)
OCGN : 1.7000 (+3.66%)
Ocugen (OCGN) Q1 2023 Earnings Call Transcript

OCGN earnings call for the period ending March 31, 2023.

OCGN : 1.7000 (+3.66%)

Business Summary

Ocugen Inc. is a clinical stage biopharmaceutical company. It is focused on discovering, developing and commercializing therapies which address rare and underserved eye diseases. The company's product pipeline consists of OCU400, OCU300, OCU100 and OCU200 which are in clinical stage. Ocugen Inc., formerly...

See More

Key Turning Points

3rd Resistance Point 1.8533
2nd Resistance Point 1.7867
1st Resistance Point 1.7433
Last Price 1.7000
1st Support Level 1.6333
2nd Support Level 1.5667
3rd Support Level 1.5233

See More

52-Week High 2.1050
Last Price 1.7000
Fibonacci 61.8% 1.4327
Fibonacci 50% 1.2250
Fibonacci 38.2% 1.0173
52-Week Low 0.3450

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar